We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Our Bourgoin, France, oral solid dose (OSD) facility is equipped with cutting-edge technologies to develop and manufacture a wide range of drug products, including highly potent APIs. Our end-to-end capabilities allow us to handle quantities from grams for preclinical phases to hundreds of kilograms for clinical studies and commercial production.
Additionally, the expertise of Thermo Fisher Scientific’s onsite staff enables our customers to navigate complex scientific and technical challenges throughout the development and manufacturing lifecycle. With advanced equipment and comprehensive services, we support the evolving demands of small molecule pharmaceutical development.
Watch as Pascal Taillardat, technical operations manager, discusses the range of services available at our Bourgoin, France, facility.
See more: